MUMBAI (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/Z4JEqFzuWA4/story01.htm
Read More
Thanks for sharing, this is a fantastic post.Thanks Again. Fantastic.
ReplyDelete